DongKook Pharmaceutical Statistics

Total Valuation

DongKook Pharmaceutical has a market cap or net worth of KRW 718.44 billion. The enterprise value is 786.86 billion.

Market Cap	718.44B
Enterprise Value	786.86B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

DongKook Pharmaceutical has 43.97 million shares outstanding. The number of shares has increased by 0.08% in one year.

Shares Outstanding	43.97M
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	25.06%
Owned by Institutions (%)	20.17%
Float	23.94M

Valuation Ratios

The trailing PE ratio is 13.41 and the forward PE ratio is 11.30.

PE Ratio	13.41
Forward PE	11.30
PS Ratio	0.94
PB Ratio	1.29
P/FCF Ratio	82.53
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.99, with an EV/FCF ratio of 90.39.

EV / Earnings	14.44
EV / Sales	1.03
EV / EBITDA	7.99
EV / EBIT	10.64
EV / FCF	90.39

Financial Position

The company has a current ratio of 2.00, with a Debt / Equity ratio of 11.91.

Current Ratio	2.00
Quick Ratio	1.27
Debt / Equity	11.91
Debt / EBITDA	0.77
Debt / FCF	8.71
Interest Coverage	13.21

Financial Efficiency

Return on equity (ROE) is 9.10% and return on invested capital (ROIC) is 6.86%.

Return on Equity (ROE)	9.10%
Return on Assets (ROA)	5.46%
Return on Capital (ROIC)	6.86%
Revenue Per Employee	685.19M
Profits Per Employee	48.82M
Employee Count	1,116
Asset Turnover	0.90
Inventory Turnover	2.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+13.24%
50-Day Moving Average	17,687.60
200-Day Moving Average	17,164.70
Relative Strength Index (RSI)	37.02
Average Volume (20 Days)	141,480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DongKook Pharmaceutical had revenue of KRW 764.67 billion and earned 54.48 billion in profits. Earnings per share was 1,218.48.

Revenue	764.67B
Gross Profit	427.33B
Operating Income	74.57B
Pretax Income	71.23B
Net Income	54.48B
EBITDA	99.07B
EBIT	74.57B
Earnings Per Share (EPS)	1,218.48

Full Income Statement

Balance Sheet

The company has 85.80 billion in cash and 75.82 billion in debt, giving a net cash position of 9.98 billion or 227.02 per share.

Cash & Cash Equivalents	85.80B
Total Debt	75.82B
Net Cash	9.98B
Net Cash Per Share	227.02
Equity (Book Value)	636.62B
Book Value Per Share	12,696.00
Working Capital	230.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 44.31 billion and capital expenditures -35.61 billion, giving a free cash flow of 8.71 billion.

Operating Cash Flow	44.31B
Capital Expenditures	-35.61B
Free Cash Flow	8.71B
FCF Per Share	197.99

Full Cash Flow Statement

Margins

Gross margin is 55.88%, with operating and profit margins of 9.75% and 7.13%.

Gross Margin	55.88%
Operating Margin	9.75%
Pretax Margin	9.32%
Profit Margin	7.13%
EBITDA Margin	12.96%
EBIT Margin	9.75%
FCF Margin	1.14%

Dividends & Yields

This stock pays an annual dividend of 180.00, which amounts to a dividend yield of 1.10%.

Dividend Per Share	180.00
Dividend Yield	1.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	15.26%
Buyback Yield	-0.08%
Shareholder Yield	1.03%
Earnings Yield	7.46%
FCF Yield	1.21%

Dividend Details

Stock Splits

The last stock split was on August 24, 2020. It was a forward split with a ratio of 5.

Last Split Date	Aug 24, 2020
Split Type	Forward
Split Ratio	5